- Home
- GANX vs PEW Comparison
GANX vs PEW Comparison
Compare GANX & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GANX | PEW |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.6M | 72.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GANX | PEW |
|---|---|---|
| Price | $1.70 | $2.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $7.50 | $6.75 |
| AVG Volume (30 Days) | 629.3K | ★ 895.6K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $55,180.00 | N/A |
| Revenue This Year | N/A | $5.25 |
| Revenue Next Year | N/A | $7.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.41 | $2.25 |
| 52 Week High | $4.34 | $7.19 |
Technical Indicators
Market Signals| Indicator | GANX | PEW |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 47.99 |
| Support Level | $1.65 | $2.26 |
| Resistance Level | $2.15 | $3.18 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 36.60 | 42.31 |
Price Performance
Historical ComparisonAbout GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
About PEW GrabAGun Digital Holdings Inc.
GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition and related accessories. The Company's firearm products are ordered and paid for by customers online through the Company's eCommerce site and mobile app and are delivered to them on-premises through their choice of federal firearm licensed dealers nationwide. The Company's network of localized firearm dealers perform background checks on firearms purchasers and complete sales forms as mandated by federal and state firearm regulations.